Nestlé Health Science - Alfamino® Infant - Infant Formula

Healthcare professionals may recommend an amino-acid based formula such as Alfamino®, for the management of food allergies (including the most common one, cow’s milk protein allergy) or for other medical conditions. The formula contains free amino acids and not intact protein which helps minimize the chance of an allergic reaction.

This product has been clinically shown to be hypoallergenic and is available for patients requiring a hypoallergenic amino acid-based formula. The suitability and use of a hypoallergenic formula should be determined by an experienced health care professional.

Potato starch is a minor contributing carbohydrate source in Alfamino and is used for its emulsification properties during manufacturing. The ingredients in Alfamino, including the potato starch, are carefully selected and screened.

24 months from production. Look at the bottom of the can for the expiration date. However, once opened, the contents of the can should be used within 1 month.

Hypoallergenic, amino acid-based formulas are not designed for use in the NICU, and these formulas are generally not used routinely in such a setting. None of the currently available products have been formulated to meet the nutritional requirements of the medically compromised premature neonate, and therefore are not indicated for use in this patient population. However, the use of such a product in a premature infant is ultimately up to the healthcare provider.

Alfamino Infant is formulated to meet the macro- and micronutrient requirements to support optimal growth and nutrition of healthy, full-term infants. Premature neonates, including medically compromised premature neonates, have unique nutrient requirements separate from healthy full-term infants and should be evaluated by a qualified healthcare professional. The use of this product in a premature infant is not recommended. The suitability of any formula, including supplementation with modulars, should be addressed by a qualified healthcare professional familiar with the case history of the patient. As with any powdered formula product, use with immune-compromised infants & children is not recommended.

Both Alfamino formulas contain a unique lipid blend that is designed to support tolerance: Alfamino Infant formula contains 43% of fat as MCT (10% more than competitors), and Alfamino Junior contains 65% of fat as MCT (>30% more than competitors). Because Alfamino formulas are indicated for both food protein allergies and malabsorption, the MCT content can provide a nutritional advantage for children with fat malabsorption (like short bowel syndrome).* If a customer prefers to carry only one amino acid-based formula on formulary, Alfamino may have an advantage due to the higher MCT for patients with malabsorption. Alfamino is truly a dual use product: i.e. it contains a hypoallergenic amino acid-based nitrogen source, and a high MCT content to support tolerance in children with fat-malabsorptive conditions.

*MCTs do not require traditional fat metabolism and, are therefore more easily absorbed directly into the enterocyte and are transported through the portal vein to the liver. As a result, MCTs are absorbed more rapidly than long chain triglycerides (Bach et al, 1982). Also, MCT oils are valuable in a number of clinical situations because they are digested quickly and less likely to be affected by intestinal factors that inhibit fat absorption (Krause, 2012).

Yes, Alfamino WIC & Medicaid approved